Omeprazole, a substituted benzimidazole, is an inhibitor of gastric acid secretion. It inhibits gastric acid secretion by blocking hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell. After oral administration, the onset of the antisecretory effect occurs within one hour, with the maximum effect occurring within two hours and inhibition of secretion lasts up to 72 hours. When the drug is discontinued, secretory activity returns gradually, over 3 to 5 days.
Related products
-73%
Albion Pharmaceuticals Ltd.
-48%
Astra Biopharmaceuticals Ltd.
-74%
Albion Pharmaceuticals Ltd.
-35%
Albion Pharmaceuticals Ltd.
-67%
Medimet Pharmaceuticals Ltd.
-35%
Omeprazole
-25%
ACI Pharmaceuticals Ltd
-68%
Omeprazole